Geneos Wealth Management’s Ametek AME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-681
Closed -$123K 2501
2025
Q2
$123K Buy
681
+49
+8% +$8.43K ﹤0.01% 1166
2025
Q1
$109K Buy
632
+399
+171% +$72.5K ﹤0.01% 1127
2024
Q4
$42K Buy
233
+70
+43% +$12.8K ﹤0.01% 1387
2024
Q3
$28K Buy
+163
New +$27.2K ﹤0.01% 1424
2021
Q2
Sell
-45
Closed -$6K 2851
2021
Q1
$6K Buy
+45
New +$5.43K ﹤0.01% 2574
2019
Q3
Sell
-61
Closed -$5K 2488
2019
Q2
$5K Hold
61
﹤0.01% 2096
2019
Q1
$5K Sell
61
-1,600
-96% -$122K ﹤0.01% 2020
2018
Q4
$110K Buy
1,661
+61
+4% +$4.38K 0.01% 807
2018
Q3
$126K Hold
1,600
0.01% 806
2018
Q2
$115K Hold
1,600
0.01% 737
2018
Q1
$121K Hold
1,600
0.01% 687
2017
Q4
$115K Sell
1,600
-1,823
-53% -$127K 0.01% 698
2017
Q3
$226K Hold
3,423
0.02% 479
2017
Q2
$207K Sell
3,423
-240
-7% -$14.1K 0.02% 489
2017
Q1
$198K Sell
3,663
-150
-4% -$7.91K 0.02% 483
2016
Q4
$185K Sell
3,813
-435
-10% -$20.6K 0.02% 472
2016
Q3
$202K Sell
4,248
-500
-11% -$23.8K 0.03% 442
2016
Q2
$220K Hold
4,748
0.03% 412
2016
Q1
$237K Buy
+4,748
New +$226K 0.04% 396

Other funds holding AME

Geneos Wealth Management's AME Position: Q3 2025 in Review

Geneos Wealth Management sold out of Ametek (AME) in Q3 2025, closing a stake of 681 shares — an estimated $123K sold.

Geneos Wealth Management first reported a position in AME in Q1 2016 and held it in 19 quarters. The position peaked at $237K in Q1 2016. 1,034 funds tracked by Wall St. Rank hold AME as of Q3 2025.

  • Geneos Wealth Management reported no remaining Ametek position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 681 Ametek shares in Q3 2025, an estimated $123K.
  • Geneos Wealth Management first reported a position in Ametek in Q1 2016 and held it in 19 quarters.
  • Geneos Wealth Management's Ametek position peaked at $237K in Q1 2016.
  • 1,034 funds tracked by Wall St. Rank held Ametek as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.